Annabelle A. Okada

7.7k total citations
144 papers, 4.3k citations indexed

About

Annabelle A. Okada is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Annabelle A. Okada has authored 144 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Ophthalmology, 40 papers in Radiology, Nuclear Medicine and Imaging and 24 papers in Rheumatology. Recurrent topics in Annabelle A. Okada's work include Ocular Diseases and Behçet’s Syndrome (75 papers), Retinal Diseases and Treatments (50 papers) and Retinal and Optic Conditions (50 papers). Annabelle A. Okada is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (75 papers), Retinal Diseases and Treatments (50 papers) and Retinal and Optic Conditions (50 papers). Annabelle A. Okada collaborates with scholars based in Japan, United States and United Kingdom. Annabelle A. Okada's co-authors include Hiroshi Keino, Takayo Watanabe, Ann Sullivan Baker, R. Paul Johnson, W. Conrad Liles, Donald J. D’Amico, Akito Hirakata, Tetsuo Hida, Wakako Taki and Makiko Nakayama and has published in prestigious journals such as PEDIATRICS, International Journal of Molecular Sciences and Ophthalmology.

In The Last Decade

Annabelle A. Okada

138 papers receiving 4.2k citations

Peers

Countries citing papers authored by Annabelle A. Okada

Since Specialization

Citations

This map shows the geographic impact of Annabelle A. Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabelle A. Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabelle A. Okada more than expected).

Fields of papers citing papers by Annabelle A. Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabelle A. Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabelle A. Okada. The network helps show where Annabelle A. Okada may publish in the future.

Co-authorship network of co-authors of Annabelle A. Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Annabelle A. Okada. A scholar is included among the top collaborators of Annabelle A. Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabelle A. Okada. Annabelle A. Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degeneration 2025 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Keiko Kataoka, Koji Tanaka, (unknown), (unknown), (unknown), Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, (unknown), Ryo Mukai, Yutaka Kato, Nobuhiro Terao, (unknown), (unknown), Moeko Kawai, (unknown), (unknown), (unknown), Ryusaburo Mori, Annabelle A. Okada	0
2	FACTORS PREDICTIVE OF PERSISTENT SUBRETINAL FLUID IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY 2024 ·Retina ·(unknown), Keiko Kataoka, Yuji Yoshikawa, Makiko Nakayama, Akiko Yamamoto, Annabelle A. Okada	0
3	Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial 2024 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, (unknown), (unknown), Annabelle A. Okada, (unknown)	1
4	Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study 2023 ·Frontiers in Medicine ·Masaru Takeuchi, Yoshihiko Usui, Kenichi Namba, Hiroshi Keino, (unknown), (unknown), Hiroshi Takase, Koju Kamoi, (unknown), Takako Ito, Kei Nakai, Kazuichi Maruyama, Eri Kobayashi, (unknown), Tomohito Sato, Nobuyuki Ohguro, Junko Hori, Annabelle A. Okada, Koh‐Hei Sonoda, Nobuhisa Mizuki, Hiroshi Gotô	7
5	Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study 2021 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Masahito Ohji, Annabelle A. Okada, Koji Sasaki, (unknown), (unknown), Kanji Takahashi, (unknown)	25
6	Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure 2021 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Jean‐François Korobelnik, Anat Loewenstein, Bora Eldem, Antonia M. Joussen, Adrian Koh, George N. Lambrou, Paolo Lanzetta, Xiaoxin Li, Monica Lövestam‐Adrian, Rafael Navarro, Annabelle A. Okada, Ian Pearce, Francisco J. Rodríguez, David T. Wong, Lihteh Wu	14
7	Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD) 2020 ·Investigative Ophthalmology & Visual Science ·Paul Mitchell, Frank G. Holz, Philip Hykin, Edoardo Midena, Annabelle A. Okada, Eric H. Souied, Kanji Takahashi, Sebastián Wolf, (unknown), George Ι. Lambrou, Thomas Schmelter, Masahito Ohji	4
8	Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic 2020 ·British Journal of Ophthalmology ·Rupesh Agrawal, Ilaria Testi, Cecilia S. Lee, Edmund Tsui, Marian Blazes, Jennifer E. Thorne, Annabelle A. Okada, Justine R. Smith, Peter McCluskey, John H. Kempen, Christoph Tappeiner, Manisha Agarwal, Bahram Bodaghi, Quan Dong Nguyen, Vishali Gupta, Marc D. de Smet, Manfred Zierhut, Carlos Pavésio	17
9	Topical antibiotics and intravitreal injections 2017 ·Acta Ophthalmologica ·Alex P. Hunyor, Rohan Merani, (unknown), Jean‐François Korobelnik, Paolo Lanzetta, Annabelle A. Okada	28
10	Ancillary Testing, Diagnostic/Classification Criteria and Severity Grading in Behçet Disease 2012 ·Ocular Immunology and Inflammation ·Annabelle A. Okada, Miles Stanford, Khalid F. Tabbara	7
11	Cystoid Macular Edema in Uveitis 2010 ·Developments in ophthalmology ·Marc D. de Smet, Annabelle A. Okada	31
12	Expression of inhibin α by stromal cells of retinal angiomas excised from a patient with von Hippel-Lindau disease 2009 ·Japanese Journal of Ophthalmology ·(unknown), Makoto Inoue, Akito Hirakata, Annabelle A. Okada, Kuniko Iihara, Yasunori Fujioka	4
13	Practical Manual of Intraocular Inflammation 2008 ·Andrew W. Dick, Annabelle A. Okada, John V. Forrester	9
14	Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis 2008 ·Arthritis Research & Therapy ·Hiroshi Keino, Takayo Watanabe, Yasuhiko Sato, Mamoru Niikura, Yumiko Wada, Annabelle A. Okada	20
15	ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa. 2002 ·PubMed ·(unknown), Shuji Yamamoto, Kaoru Nakano, Motokazu Tsujikawa, Hiroyuki Morimura, Kohji Nishida, Nobuyuki Ohguro, Takashi Fujikado, (unknown), Kazuki Kuniyoshi, Annabelle A. Okada, Akito Hirakata, Yozo Miyake, Yasuo Tano	53
16	Oral administration of interferon-β suppresses experimental autoimmune uveoretinitis 2002 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Jun Suzuki, Junichi Sakai, Annabelle A. Okada, Eiko Takada, Masahiko Usui, Junichiro Mizuguchi	7
17	Effect of type I interferon on experimental autoimmune uveoretinitis in rats 1998 ·Ocular Immunology and Inflammation ·Annabelle A. Okada, Hiroshi Keino, (unknown), Junichi Sakai, Masahiko Usui, Junichiro Mizuguchi	33
18	Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine 1996 ·International Immunology ·Takeshi Kezuka, Junichi Sakai, (unknown), Masaru Takeuchi, Annabelle A. Okada, Osamu Taguchi, Masahiko Usui, (unknown), Ko Okumura	15
19	The use of fibrin tissue adhesive the treatment of macular holes 1995 ·Investigative Ophthalmology & Visual Science ·Takuya Iwasaki, (unknown), Kenta Yamamoto, Annabelle A. Okada, Marcia L. Usui	6
20	OXIDATIVE STRESS IN THE DEVELOPMENT OF CATARACT AS A COMPLICATION OF UVEITIS 1994 ·Investigative Ophthalmology & Visual Science ·Hideo Goto, Naoyuki Yamakawa, (unknown), Annabelle A. Okada, Masahiko Usui	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact